Vimarsana
Biggest News Aggregation in the World

Cell Microsystems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Microsystems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Microsystems Today - Breaking & Trending Today

Cell Microsystems and OMNI Life Science Announce Partnership - Vimarsana News

Cell Microsystems and OMNI Life Science Announce Partnership

Cell Microsystems, a leading provider of advanced tools for cell biology, is excited to announce a strategic partnership with OMNI Life Science (OLS), a renowned German cell biology company.

NC Biotech Center awards 21 grants, loans totaling nearly $1.8M across state - Vimarsana News

NC Biotech Center awards 21 grants, loans totaling nearly $1.8M across state

The North Carolina Biotechnology Center awarded 21 grants and loans totaling about $1.79 million to bioscience companies, universities and non-profit organizations in the first quarter of its fiscal year. Here are the details.

Durham biotech startup acquires California company after raising $6.5M - Vimarsana News

Durham biotech startup acquires California company after raising $6.5M

Cell Microsystems recently announced its acquisition of Oakland, California-based Fluxion Biosciences, a developer of automated patch clamp technology and cell-based assay tools. Here's what's happening.

Taking the fear out of iPS cell line development - Vimarsana News

Taking the fear out of iPS cell line development

Discover how to improve the efficiency and success of iPSC cloning, while decreasing time, expense, and effort.

Durham-based Cell Microsystems takes big growth steps with funding, acquisition - Vimarsana News

Durham-based Cell Microsystems takes big growth steps with funding, acquisition

Cell Microsystems is a biotechnology company that has created the CellRaft® technology. Concurrent to the acquisition the company announced Series B financing led by Telegraph Hill Partners.